zintick

Sagimet Biosciences SGMT

Sagimet Biosciences Inc. · Nasdaq · Pharmaceutical Preparations

$10.74+3.07%close on Oct. 28, 2026 · volume 1.2M · Yahoo Finance

Price, last 47 sessions

$8.00$9.00$10.00$11.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $11.17 · low $7.55 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Aug. 14, 2026George Kemble
director
Sold
10b5-1 plan
350,987$10.23$3.59 million
Aug. 11, 2026George Kemble
director
Sold
10b5-1 plan
20,206$9.95$201,147

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 12 →
  • 8-KOct. 22, 2026, 7:15 a.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedSagimet Biosciences Updates Investor Presentation; First AURORA Phase 3 Patient Dosed, Cash Cited at $257.6 Million

  • SCHEDULE 13GOct. 7, 2026, 6:28 p.m. ETView on SEC.gov
  • 8-KSept. 30, 2026, 6 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Financial statements and exhibits

  • 424B5Sept. 30, 2026, 5:53 p.m. ETView on SEC.gov
  • 8-KSept. 30, 2026, 6:09 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

  • 4Aug. 17, 2026, 4:05 p.m. ETView on SEC.gov
  • SCHEDULE 13GAug. 14, 2026, 6:09 a.m. ETView on SEC.gov
  • 8-KAug. 13, 2026, 7:05 a.m. ETView on SEC.gov

    Other events